Psoriasis Treatment Market to be Worth $35.07 Billion by 2031

Psoriasis Treatment Market Size, Share, Forecast, & Trends Analysis by Treatment (TNF Inhibitor, Interleukin, Corticosteroids, Calcitrol, Retinoids, Calcineurin, Methotrexate) Disease (Plaque Psoriasis, Psoriatic Arthritis) – Global Forecast to 2031

Meticulous Research^®—a leading global market research company, published a research report titled, ‘Psoriasis Treatment Market Size, Share, Forecast, & Trends Analysis by Treatment (TNF Inhibitor, Interleukin, Corticosteroids, Calcitrol, Retinoids, Calcineurin, Methotrexate) Disease (Plaque Psoriasis, Psoriatic Arthritis) – Global Forecast to 2031.’

According to this latest publication from Meticulous Research®, the psoriasis treatment market is projected to reach $35.07 billion by 2031, at a CAGR of 9.8% during the forecast period 2024–2031. The growth of this market is driven by the high burden of psoriasis, advancements in treatment options, improved psoriasis diagnosis, improved understanding of disease pathogenesis, high rate of elderly people being more susceptible to psoriasis. Moreover, the rising awareness regarding psoriasis, growing use of combination therapies for treatment, and growing research regarding psoriasis are expected to generate growth opportunities for the players operating in the psoriasis treatment market.

The key players operating in the psoriasis treatment market are AbbVie Inc. (U.S.), AstraZeneca Plc (U.K.), Boehringer Ingelheim (Germany), Celgene Corporation (U.S.), Eli Lilly and Company (U.S.), Johnson and Johnson (U.S.), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Biogen, Inc. (U.S.), LEO Pharma A/S (Denmark), Sun Pharmaceutical Industries Ltd. (India), and Dr. Reddy’s Laboratories Ltd. (India).

Psoriasis Treatment Market: Future Outlook

The psoriasis treatment market is segmented by Treatment Type (Biologic Drugs [TNF Inhibitors {Infliximab, Adalimumab, Etanercept, Other TNF Inhibitors}, Interleukin Inhibitors {Guselkumab, Risankizumab, Tildrakizumab}, Others], Topical Treatments [Corticosteroids {Hydrocortisone, Desonide, Betamethasone, Others}, Vitamin D Analogs {Calcitrol, Calcipotriol, Tacalcitol}, Retinoids, Calcineurin Inhibitors], Systemic Treatments [Methotrexate, Cyclosporine, Acitretin, Others]), Disease Type (Plaque Psoriasis, Psoriatic Arthritis, Others), Route of Administration (Oral, Topical, Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/E-commerce Platforms), and Geography. The study also evaluates industry competitors and analyzes the market at regional and country levels.

Based on treatment type, the market is segmented into biologic drugs, topical treatments, and systemic treatments. The biologics drugs segment is projected to witness the highest growth rate during the forecast period of 2024–2031. The growth of this segment is driven by the growing adoption of Interleukin inhibitors due to their high efficacy and favorable safety profiles, advancements in biologic drug development, and initiatives by the players to launch new biologics for psoriasis.

Based on disease type, the psoriasis treatment market is segmented into plaque psoriasis, psoriatic arthritis, and others. The psoriatic arthritis segment is expected to grow at the highest CAGR of 7.1% during the forecast period of 2024-2031. The rising prevalence of psoriatic arthritis due to the risk of patients of plaque psoriasis developing arthritic psoriasis, rising awareness regarding the disease, and advancements in treatment options drive the segment growth.

Based on administration route, the psoriasis treatment market is segmented into oral, topical, and injectable. In 2024, the injectable segment is expected to account for the largest share of the psoriasis treatment market. Biologic drugs are known for their high effectiveness and widespread availability, particularly in the treatment of psoriasis. Most biologic drugs, recognized for their potent therapeutic effects, are administered via injections. Healthcare providers favor injectables because they allow for precise dosing and are easier to monitor. This preference significantly contributes to the dominant market share of injectable biologics.

Based on distribution channel, the psoriasis treatment market is segmented into hospital pharmacies, retail pharmacies, and online. In 2024, the hospital pharmacies segment is expected to account for the largest share of the market. Hospitals are the primary centers for diagnosing and treating psoriasis, making hospital pharmacies crucial distribution points for psoriasis medications. In developing countries, patients often prefer hospitals for their medical needs. Since hospital pharmacies maintain a diverse inventory of medications for various conditions, they hold the largest market share for psoriasis medications.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Spain, Italy, Netherlands, Switzerland, Poland, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, New Zealand, Rest of APAC), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa.

Based on geography, in 2024, North America is expected to account for the largest share of the psoriasis treatment market. Additionally, in 2024, the U.S. is expected to account for the largest share of the psoriasis treatment market. The large market share is attributed to the high prevalence of psoriasis, high adoption of personalized therapies, well-developed health infrastructure, and continuous research and development for psoriasis, translating into new treatment approaches and drugs.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5908

Key questions answered in the report-

What is the current value of revenue generated by medicines for psoriasis across the globe?
At what rate is the demand for psoriasis treatment projected to grow for the next 5-7 years?
What is the historical market size and growth rate for psoriasis treatment across the globe?
What are the major factors impacting the growth of this market at the global and regional levels? What are the major opportunities for existing market players and new entrants in the market?
Which segments are creating major traction for the vendors in this market in terms of treatment type, disease type, route of administration, and distribution channel?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the psoriasis treatment market?
Who are the major players in the psoriasis treatment market? And what are their specific apps offered in the industry?
What recent developments have taken place in the psoriasis treatment market, and how these strategic developments are creating a global impact in this market?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research